Heart Test Laboratories(HSCS)

Search documents
Heart Test Laboratories(HSCS) - 2023 Q2 - Quarterly Report
2022-12-15 21:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-41422 HEART TEST LABORATORIES, INC. (Exact Name of Registrant as Specified in its Charter) TEXAS 26-1344466 ( State or other jurisdiction of incorporation or org ...
Heart Test Laboratories (HSCS) Presents At LD Micro 15th Annual Main Event Conference - Presentation
2022-11-07 17:07
Heart Test Laboratories, Inc. Nasdaq: HSCS MyoVista® Wavelet ECG Game Changing AI Technology for the Early Detection of Heart Disease. Not FDA Cleared or Approved AI + Advanced Signal Processing - Designed to Revolutionize ECG for Heart Screening October 26, 2022 AI and Wavelet Signal Processing INVESTOR OVERVIEW SAFE HARBOR Certain data in this presentation was obtained from various external sources, and neither "HeartSciences" or the "Company" nor its affiliates or representatives has verified such data w ...
Heart Test Laboratories(HSCS) - 2023 Q1 - Quarterly Report
2022-09-12 20:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-41422 HEART TEST LABORATORIES, INC. (Exact Name of Registrant as Specified in its Charter) TEXAS 26-1344466 ( State or other jurisdiction of incorporation or organi ...
Heart Test Laboratories(HSCS) - 2022 Q4 - Annual Report
2022-07-29 21:01
Table of Contents Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number 001-41422 HEART TEST LABORATORIES, INC. (Exact name of Registrant as specified in its Charter) (State or other jurisdictio ...